Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS

Class:IdLiteratureReference:6787739
_displayNameSevere congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS
_timestamp2015-07-16 14:22:07
author[Person:1606515] Vandenberghe, P
[Person:6787726] Beel, Karolien
created[InstanceEdit:6787740] Jupe, Steve, 2015-07-16
journalPediatr Rep
pagese9
pubMedIdentifier22053285
titleSevere congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS
volume3
year2011
(literatureReference)[Summation:6787736] The granulocyte colony-stimulating factor receptor (CSF3R, G...
[Pathway:9674555] Signaling by CSF3 (G-CSF) [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS (6787739)